Mreininger (Talk | contribs) |
Mreininger (Talk | contribs) |
||
Line 237: | Line 237: | ||
<div id="1" class="yolo" style="display:none;"> | <div id="1" class="yolo" style="display:none;"> | ||
<p> | <p> | ||
− | <br> • Preparation of growth media </br> | + | <br> • Preparation of growth media. </br> |
<br> • Interlab Challenge 2017: Transformations of the plasmids into <i>E. coli</i> DH5α <br>for more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site. </br> | <br> • Interlab Challenge 2017: Transformations of the plasmids into <i>E. coli</i> DH5α <br>for more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site. </br> | ||
− | <br> • <i>E. Coli</i> DH10B cells made chemically competent</br> | + | <br> • <i>E. Coli</i> DH10B cells were made chemically competent.</br> |
<br> • Miniprep of GG plasmids: | <br> • Miniprep of GG plasmids: | ||
<a href="#BB1_01" class="bgscroll"> BB1_01</a>, <a href="#BB1_02" class="bgscroll"> BB1_02</a>, <a href="#BB1_03" class="bgscroll"> BB1_03</a>, <a href="#BB1_04" class="bgscroll"> BB1_04</a>, <a href="#BB1_05" class="bgscroll"> BB1_05</a>, <a href="#BB1_06" class="bgscroll"> BB1_06</a>, <a href="#BB1_07" class="bgscroll"> BB1_07</a>, <a href="#BB1_08" class="bgscroll"> BB1_08</a></br> | <a href="#BB1_01" class="bgscroll"> BB1_01</a>, <a href="#BB1_02" class="bgscroll"> BB1_02</a>, <a href="#BB1_03" class="bgscroll"> BB1_03</a>, <a href="#BB1_04" class="bgscroll"> BB1_04</a>, <a href="#BB1_05" class="bgscroll"> BB1_05</a>, <a href="#BB1_06" class="bgscroll"> BB1_06</a>, <a href="#BB1_07" class="bgscroll"> BB1_07</a>, <a href="#BB1_08" class="bgscroll"> BB1_08</a></br> | ||
Line 284: | Line 284: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_09" class="bgscroll"> BB1_09</a>, <a href="#BB1_10" class="bgscroll"> BB1_10</a>, <a href="#BB1_11" class="bgscroll"> BB1_11</a>, <a href="#BB1_12" class="bgscroll"> BB1_12</a>, <a href="#BB1_13" class="bgscroll"> BB1_13</a>, BB2_01 (unsuccessful), <a href="#BB2_02" class="bgscroll"> BB2_02</a>, <a href="#BB2_03" class="bgscroll"> BB2_03</a>, <a href="#BB2_04" class="bgscroll"> BB2_04</a>, BB2_05 (unsuccessful)</br> | <br><br>• Golden Gate Assembly of <a href="#BB1_09" class="bgscroll"> BB1_09</a>, <a href="#BB1_10" class="bgscroll"> BB1_10</a>, <a href="#BB1_11" class="bgscroll"> BB1_11</a>, <a href="#BB1_12" class="bgscroll"> BB1_12</a>, <a href="#BB1_13" class="bgscroll"> BB1_13</a>, BB2_01 (unsuccessful), <a href="#BB2_02" class="bgscroll"> BB2_02</a>, <a href="#BB2_03" class="bgscroll"> BB2_03</a>, <a href="#BB2_04" class="bgscroll"> BB2_04</a>, BB2_05 (unsuccessful)</br> | ||
− | GG-products | + | GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• pSIM5 pre-cultures (DH5alpha + BL21(DE3))</br> | <br>• pSIM5 pre-cultures (DH5alpha + BL21(DE3))</br> | ||
<br>• Transformation of HSM174 + pSIM5 (unsuccessful)</br> | <br>• Transformation of HSM174 + pSIM5 (unsuccessful)</br> | ||
− | <br>• Yeast S288C gDNA extracted </br> | + | <br>• Yeast S288C gDNA was extracted. </br> |
<div id="BB1_09" class="modalDialog "> | <div id="BB1_09" class="modalDialog "> | ||
Line 329: | Line 329: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, BB2_01 (unsuccessful, even with new BBa_23101 promoter), BB2_05 (unsuccessful), <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a>, <a href="#BB2_14" class="bgscroll"> BB2_14</a>, <a href="#BB2_15" class="bgscroll"> BB2_15</a>, <a href="#BB2_16" class="bgscroll"> BB2_16</a>, C-PPP_01 (unsuccessful)</br> | <br><br>• Golden Gate Assembly of <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, BB2_01 (unsuccessful, even with new BBa_23101 promoter), BB2_05 (unsuccessful), <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a>, <a href="#BB2_14" class="bgscroll"> BB2_14</a>, <a href="#BB2_15" class="bgscroll"> BB2_15</a>, <a href="#BB2_16" class="bgscroll"> BB2_16</a>, C-PPP_01 (unsuccessful)</br> | ||
− | GG-products | + | GG-products were transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Sent for Sequencing: <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, <a href="#BB2_01" class="bgscroll"> BB2_01</a>, <a href="#BB2_05" class="bgscroll"> BB2_05</a>, <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a></br> | <br>• Sent for Sequencing: <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, <a href="#BB2_01" class="bgscroll"> BB2_01</a>, <a href="#BB2_05" class="bgscroll"> BB2_05</a>, <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a></br> | ||
<br>• Interlab Challenge 2017: Performance of the measurements. For more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site.</br> | <br>• Interlab Challenge 2017: Performance of the measurements. For more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site.</br> |
Revision as of 15:51, 1 November 2017
Notebook.
All protocols we used for the methods can be found here:
Protocol
For further information regarding our Golden Gate Assembly products, please refer to our part collection site. The list of our primers can be found here.
Week 1 (03/07-07/07)
Week 2 (10/07-14/07)
Week 3 (17/07-21/07)
Week 4 (24/07-28/07)
Week 5 (31/07-04/08)
Week 6 (07/08-11/08)
Week 7 (14/08-18/08)
Week 8 (21/08-25/08)
Week 9 (28/08-01/09)
Week 10 (04/09-08/09)
Week 11 (11/09-15/09)
Week 12 (18/09-22/09)
Week 13 (25/09-29/09)
Week 14 (02/10-06/10)
Week 15 (09/10-13/10)